Jason Pantarotto

2.2k total citations · 1 hit paper
45 papers, 1.2k citations indexed

About

Jason Pantarotto is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jason Pantarotto has authored 45 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 19 papers in Radiation and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jason Pantarotto's work include Lung Cancer Diagnosis and Treatment (21 papers), Advanced Radiotherapy Techniques (19 papers) and Medical Imaging Techniques and Applications (8 papers). Jason Pantarotto is often cited by papers focused on Lung Cancer Diagnosis and Treatment (21 papers), Advanced Radiotherapy Techniques (19 papers) and Medical Imaging Techniques and Applications (8 papers). Jason Pantarotto collaborates with scholars based in Canada, Netherlands and United States. Jason Pantarotto's co-authors include Andrea Bezjak, Corinne Faivre‐Finn, Jan P. van Meerbeeck, P. Fournel, Adityanarayan Bhatnagar, Linda Ashcroft, R. McMenemin, M. Snee, Veerle Surmont and Mary O’Brien and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Lancet Oncology.

In The Last Decade

Jason Pantarotto

41 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial

2017 354 citations Corinne Faivre‐Finn, M. Snee et al. The Lancet Oncology profile →

Peers

Countries citing papers authored by Jason Pantarotto

Since Specialization

Citations

This map shows the geographic impact of Jason Pantarotto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Pantarotto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Pantarotto more than expected).

Fields of papers citing papers by Jason Pantarotto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Pantarotto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Pantarotto. The network helps show where Jason Pantarotto may publish in the future.

Co-authorship network of co-authors of Jason Pantarotto

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Pantarotto. A scholar is included among the top collaborators of Jason Pantarotto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Pantarotto. Jason Pantarotto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Health care system factors associated with receipt of treatment and treatment intent in stage III non-small cell lung cancer: A population-based study in Ontario 2024 ·Clinical and Translational Radiation Oncology ·Stéphane Thibodeau, Paul Nguyen, Andrew Robinson, Fábio Ynoe de Moraes, Jason Pantarotto, Timothy P. Hanna	0
2	Ablative vs. Non-Ablative Radiotherapy in Palliating Locally Advanced Pancreatic Cancer: A Single Institution Experience and a Systematic Review of the Literature 2023 ·Cancers ·(unknown), Kristopher Dennis, (unknown), Jason Pantarotto	2
3	Cancer Clinic Redesign: Opportunities for Resource Optimization 2022 ·Current Oncology ·Michael Fung‐Kee‐Fung, (unknown), Bill Davies, Stephanie Pick, (unknown), David J. Stewart, M. Neil Reaume, (unknown), Katelyn Balchin, Robert M. MacRae, (unknown), Julie Renaud, (unknown), (unknown), Jason Pantarotto	0
4	Implementing A One-Day Testing Model Improves Timeliness of Workup for Patients with Lung Cancer 2019 ·Current Oncology ·(unknown), (unknown), (unknown), Linda Murphy, (unknown), Jason Pantarotto, Michael Fung‐Kee‐Fung, Donna E. Maziak	3
5	Time to Diagnosis and Treatment with Palliative Radiotherapy among Inuit Patients with Cancer from the Arctic Territory of Nunavut, Canada 2019 ·Clinical Oncology ·Jessica L. Chan, Kelly Linden, (unknown), Julie Renaud, (unknown), Stuart MacDonald, Marc Gaudet, Jason Pantarotto, Timothy R. Asmis, Ben J. Slotman, Kristopher Dennis	9
6	A Phase II Multi-institutional Clinical Trial Assessing Fractionated Simultaneous In-Field Boost Radiotherapy for Brain Oligometastases 2019 ·Cureus ·George Rodrigues, Slav Yartsev, David Roberge, Robert M. MacRae, Wilson Roa, Valérie Panet-Raymond, Giuseppina Laura Masucci, Brian Yaremko, David D’Souza, David A. Palma, Tracy Sexton, Edward Yu, Jason Pantarotto, Belal Ahmad, Barbara Fisher, A. Rashid Dar, Carole Lambert, Gregory R. Pond, Keng Yeow Tay, Glenn Bauman	5
7	Clinical Specialist Radiation Therapist in Palliative Radiation Therapy: Report of an Orientation, Training, and Support Program 2019 ·Journal of medical imaging and radiation sciences ·Kelly Linden, Julie Renaud, (unknown), Marc Gaudet, (unknown), Jason Pantarotto, Kristopher Dennis	16
8	Radical Treatment of Stage II Non–small-cell Lung Cancer With Nonsurgical Approaches: A Multi-institution Report of Outcomes 2017 ·Clinical Lung Cancer ·Shaan Dudani, Xiaofu Zhu, Daniel Yokom, (unknown), Cheryl Ho, Jason Pantarotto, Natasha B. Leighl, Tinghua Zhang, Paul Wheatley‐Price	4
9	Quantitative texture analysis on pre-treatment computed tomography predicts local recurrence in stage I non-small cell lung cancer following stereotactic radiation therapy 2017 ·Quantitative Imaging in Medicine and Surgery ·Carole Dennie, Rebecca E. Thornhill, Carolina A. Souza, (unknown), Jason Pantarotto, Robert M. MacRae, (unknown)	11
10	Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung cancer 2017 ·Clinical and Translational Radiation Oncology ·Oliver Holmes, Robert M. MacRae, (unknown), P. Cross, Vimoj Nair, (unknown), Jason Pantarotto	4
11	Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial breakdown → 2017 ·The Lancet Oncology ·Corinne Faivre‐Finn, M. Snee, Linda Ashcroft, W. Appel, Fabrice Barlési, Adityanarayan Bhatnagar, Andrea Bezjak, Felipe Cardenal, P. Fournel, Susan Harden, C. Le Péchoux, R. McMenemin, N. Mohammed, Mary O’Brien, Jason Pantarotto, Veerle Surmont, Jan P. van Meerbeeck, Penella J. Woll, Paul Lorigan, Fiona Blackhall	354
12	Approach to the non-operative management of patients with stage II non-small cell lung cancer (NSCLC): A survey of Canadian medical and radiation oncologists 2016 ·Lung Cancer ·Shaan Dudani, Natasha B. Leighl, Cheryl Ho, Jason Pantarotto, Xiaofu Zhu, (unknown), Paul Wheatley‐Price	7
13	Prognostic Factors in the Radical Nonsurgical Treatment of Stage IIIB Non–Small-Cell Lung Cancer 2014 ·Clinical Lung Cancer ·(unknown), Brian C. Healy, Jason Pantarotto, Scott A. Laurie, Robert M. MacRae, Elham Sabri, Paul Wheatley‐Price	12
14	Pretreatment [18F]-fluoro-2-deoxy-glucose Positron Emission Tomography Maximum Standardized Uptake Value as Predictor of Distant Metastasis in Early-Stage Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy: Rethinking the Role of Positron Emission Tomography in Personalizing Treatment Based on Risk Status 2014 ·International Journal of Radiation OncologyBiologyPhysics ·Vimoj Nair, Robert M. MacRae, (unknown), Jason Pantarotto	33
15	Upper abdominal normal organ contouring guidelines and atlas: A Radiation Therapy Oncology Group consensus 2013 ·Practical Radiation Oncology ·Salma K. Jabbour, Sameh Hashem, Walter Bosch, Tae Kyoung Kim, Steven E. Finkelstein, Bethany Anderson, Edgar Ben‐Josef, Christopher H. Crane, Karyn A. Goodman, Michael G. Haddock, Joseph M. Herman, Theodore S. Hong, Lisa A. Kachnic, Harvey J. Mamon, Jason Pantarotto, Laura A. Dawson	94
16	Clinical use of a novel in vivo 4D monitoring system for simultaneous patient motion and dose measurements 2011 ·Radiotherapy and Oncology ·Amanda Cherpak, Joanna Cygler, (unknown), Jason Pantarotto, Robert M. MacRae, Gad Perry	13
17	Inferring Positions of Tumor and Nodes in Stage III Lung Cancer From Multiple Anatomical Surrogates Using Four-Dimensional Computed Tomography 2010 ·International Journal of Radiation OncologyBiologyPhysics ·K Malinowski, Jason Pantarotto, Suresh Senan, Thomas J. McAvoy, W DˈSouza	6
18	Role of Adaptive Radiotherapy During Concomitant Chemoradiotherapy for Lung Cancer: Analysis of Data From a Prospective Clinical Trial 2009 ·International Journal of Radiation OncologyBiologyPhysics ·F. Spoelstra, Jason Pantarotto, John R. van Sörnsen de Koste, Ben J. Slotman, Suresh Senan	26
19	Motion Analysis of 100 Mediastinal Lymph Nodes: Potential Pitfalls in Treatment Planning and Adaptive Strategies 2008 ·International Journal of Radiation OncologyBiologyPhysics ·Jason Pantarotto, Anna H.M. Piet, Andrew Vincent, John R. van Sörnsen de Koste, Suresh Senan	50
20	Smoking is associated with worse outcomes in patients with prostate cancer treated by radical radiotherapy 2006 ·British Journal of Urology ·Jason Pantarotto, Shawn Malone, Simone Dahrouge, V Gallant, Libni Eapen	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact